☰

Arnold I. Chin, Ph.D. - Publications

Affiliations: 
2002 University of California, Los Angeles, Los Angeles, CA 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Wang L, Smith BA, Balanis NG, Tsai BL, Nguyen K, Cheng MW, Obusan MB, Esedebe FN, Patel SJ, Zhang H, Clark PM, Sisk AE, Said JW, Huang J, Graeber TG, ... ... Chin AI, et al. A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes. Proceedings of the National Academy of Sciences of the United States of America. PMID 31871155 DOI: 10.1073/Pnas.1915770117  0.384
2019 Hu J, Ishihara M, Chin AI, Wu L. Establishment of xenografts of urological cancers on chicken chorioallantoic membrane (CAM) to study metastasis. Precision Clinical Medicine. 2: 140-151. PMID 31598385 DOI: 10.1093/Pcmedi/Pbz018  0.47
2019 Smith BA, Balanis NG, Tsai B, Park J, Zhang H, Said JW, Graeber TG, Witte ON, Chin* AI. MP57-09 MOLECULAR PROFILING OF SMALL CELL BLADDER CANCER: IMPLICATIONS FOR IMMUNOTHERAPEUTIC STRATEGIES Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556626.19138.D3  0.362
2017 Prado K, Zhang KX, Pellegrini M, Chin AI. Sequencing of cancer cell subpopulations identifies micrometastases in a bladder cancer patient. Oncotarget. PMID 28487492 DOI: 10.18632/Oncotarget.17312  0.374
2017 Prado K, Zhang K, Pellegrini M, Chin A. MP88-03 SEQUENCING OF A CANCER CELL SUBPOPULATION IDENTIFIES MICROMETASTASES IN BLADDER CANCER Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2728  0.372
2016 Prado K, Chin AI. How nerve-sparing technique has been applied to radiotherapy? Asian Journal of Andrology. PMID 27453071 DOI: 10.4103/1008-682X.184995  0.378
2016 Zhang H, Prado K, Zhang KX, Peek EM, Lee J, Wang X, Huang J, Li G, Pellegrini M, Chin AI. Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27189164 DOI: 10.1158/1078-0432.Ccr-15-2581  0.376
2016 Prado K, Zhang H, Chin A. MP88-02 EXPRESSION OF FORKHEAD BOX P3 IN BLADDER CANCER CELLS MODULATES SENSITIVITY TO HISTONE DEACETYLASE INHIBITORS Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2420  0.324
2015 Eggener SE, Badani K, Barocas DA, Barrisford GW, Cheng JS, Chin AI, Corcoran A, Epstein JI, George AK, Gupta GN, Hayn MH, Kauffman EC, Lane B, Liss MA, Mirza M, et al. Gleason 6 Prostate Cancer: Translating Biology into Population Health. The Journal of Urology. PMID 25849602 DOI: 10.1016/J.Juro.2015.01.126  0.386
2015 Li DR, Zhang H, Peek E, Wang S, Du L, Li G, Chin AI. Synergy of Histone-Deacetylase Inhibitor AR-42 with Cisplatin in Bladder Cancer. The Journal of Urology. PMID 25748177 DOI: 10.1016/J.Juro.2015.02.2918  0.344
2015 Peek EM, Song W, Zhang H, Huang J, Chin AI. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes. The Prostate. 75: 463-73. PMID 25597486 DOI: 10.1002/Pros.22932  0.504
2015 Zhang H, Peek E, Lee J, Zhang K, Wang X, Huang J, Li G, Pellegrini M, Chin A. MP45-18 EXPRESSION OF FOXP3Δ2 IN BLADDER CANCER EPITHELIAL CELLS IMPARTS RESISTANCE TO CHEMOTHERAPY AND INVERSELY CORRELATES TO SURVIVAL Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1516  0.33
2014 Wang JG, Huang J, Chin AI. RARP in high-risk prostate cancer: use of multi-parametric MRI and nerve sparing techniques. Asian Journal of Andrology. 16: 715-9. PMID 24969055 DOI: 10.4103/1008-682X.129942  0.323
2014 Zhang H, Chin AI. Role of Rip2 in development of tumor-infiltrating MDSCs and bladder cancer metastasis. Plos One. 9: e94793. PMID 24733360 DOI: 10.1371/Journal.Pone.0094793  0.423
2012 Peek EM, Li DR, Zhang H, Kim HP, Zhang B, Garraway IP, Chin AI. Stromal modulation of bladder cancer-initiating cells in a subcutaneous tumor model. American Journal of Cancer Research. 2: 745-51. PMID 23226620  0.302
2012 Kaplan AL, Margolis DJ, Said J, Chin AI. Primary carcinoid tumor of urinary bladder discovered on pelvic magnetic resonance imaging. Urology. 80: e55-7. PMID 23107414 DOI: 10.1016/J.Urology.2012.08.009  0.306
2012 Zhang H, Wang X, Seligson D, Pantuck A, Chin AI. Abstract 3651: Foxp3 expression correlates with survival in urothelial carcinoma of the bladder Cancer Research. 72: 3651-3651. DOI: 10.1158/1538-7445.Am2012-3651  0.381
2011 Finley DS, Pouliot F, Shuch B, Chin A, Pantuck A, Dekernion JB, Belldegrun AS. Ultrasound-based combination therapy: potential in urologic cancer. Expert Review of Anticancer Therapy. 11: 107-13. PMID 21166515 DOI: 10.1586/Era.10.174  0.39
2011 Finley DS, Pouliot F, Chin AI, Shuch B, Pantuck AJ, Belldegrun AS, Dekernion JB. Immunological therapy in urological malignancy: novel combination strategies. International Journal of Urology : Official Journal of the Japanese Urological Association. 18: 94-101. PMID 21073543 DOI: 10.1111/J.1442-2042.2010.02664.X  0.302
2010 Chin AI, Miyahira AK, Covarrubias A, Teague J, Guo B, Dempsey PW, Cheng G. Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance. Cancer Research. 70: 2595-603. PMID 20233880 DOI: 10.1158/0008-5472.Can-09-1162  0.644
2010 Chin A, Miyahara A, Covarrubias A, Teague J, Dempsey P, Cheng G. 548 TUMOR SURVEILLANCE BY TOLL-LIKE RECEPTOR 3 IN PROSTATE CANCER Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.768  0.592
2010 Stepanian S, Chan J, Shurtleff B, Levin M, Chin A, Jianyu R, Reiter R. 1167 DETECTION OF VOIDED URINARY PROSTATE STEM CELL ANTIGEN AS A HIGHLY SENSITIVE MARKER FOR UROTHELIAL TRANSITIONAL CELL CARCINOMA Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.667  0.315
2009 Chin AI, Miyahara A, Covarrubias A, Dempsey PW, Cheng G. SUPPRESSION OF PROSTATE CANCER GROWTH WITH ACTIVATION OF TOLL-LIKE RECEPTOR 3 Journal of Urology. 181: 186-186. DOI: 10.1016/S0022-5347(09)60536-X  0.562
2005 Chin AI, Dempsey PW, Cheng G. Rip2: A key molecule that regulates both innate and acquired immunity Current Medicinal Chemistry: Anti-Inflammatory and Anti-Allergy Agents. 4: 35-42. DOI: 10.2174/1568014053005264  0.514
2002 Chin AI, Dempsey PW, Bruhn K, Miller JF, Xu Y, Cheng G. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature. 416: 190-4. PMID 11894097 DOI: 10.1038/416190A  0.509
1999 Chin AI, Shu J, Shan Shi C, Yao Z, Kehrl JH, Cheng G. TANK potentiates tumor necrosis factor receptor-associated factor-mediated c-Jun N-terminal kinase/stress-activated protein kinase activation through the germinal center kinase pathway. Molecular and Cellular Biology. 19: 6665-72. PMID 10490605 DOI: 10.1128/Mcb.19.10.6665  0.491
Show low-probability matches.